Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Friday, July 31, 2026
In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a Florida man's lawsuit against OpenAI after ChatGPT repeatedly dismissed his pulmonary embolism symptoms as "not something dangerous." The case raises urgent questions about AI medical liability just as a new JAMA analysis reveals updated cholesterol guidelines now make 87.5 million US adults eligible for statins (more than 56% of the 30-to-79 population). Plus: they also discuss the FDA's first dual-ingredient OTC pain reliever, Lego MRI models cutting pediatric sedation rates by nearly half, and Europe's approval of a retinal implant that helped 84% of participants read again. Plus: oral GLP-1 competition heats up and a new smell-impairment and depression link.
(00:00) Intro & Trivia Question
(01:05) AI Medical Advice Lawsuit (OpenAI/ChatGPT)
(04:34) New Cholesterol Guidelines & Statin Eligibility
(07:05) Off The Clock GLP-1s, Lego MRI, OTC Pain Combo
(11:03) Trivia Answer
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
